C21 Investments Inc
C21 Investments Inc has a current ratio of 0.51, indicating that its current assets are insufficient to cover its current liabilities, which suggests potential liquidity challenges. The company's debt-to-equity ratio is 0.04, reflecting a relatively low level of leverage compared to industry norms. However, the company's free cash flow is negative at -1.53 million USD, which may limit its ability to fund operations or invest in growth without external financing. The company's profitability is underperforming, with a return on equity of -6.58% and a return on assets of -3.74%, both significantly below the industry median. These metrics suggest that the company is not effectively utilizing its equity or assets to generate returns, which could be a concern for investors. C21 Investments Inc's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the company's exposure to regional economic downturns or regulatory changes that could impact its primary market. The company's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year and no clear guidance for the next fiscal year. The negative operating income of -307,660 USD and net loss of -2.04 million USD indicate that the company is currently not generating sufficient revenue to cover its operating expenses. The company's risk profile includes medium liquidity risk due to its current ratio and negative free cash flow. While dilution risk is currently low, the negative net cash position after subtracting total debt suggests that the company may need to raise additional capital in the future, which could lead to share dilution. Recent filings and transcripts do not indicate any major strategic shifts or significant operational changes. The company's financial performance remains a key area of focus, with the need to improve profitability and manage liquidity effectively.
Business. C21 Investments Inc operates in the drug retailing industry, primarily generating revenue through the sale of pharmaceuticals and related health products.
Classification. C21 Investments Inc is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Drug Retailers industry with a confidence level of 0.92.
- C21 Investments Inc is experiencing negative returns on both equity and assets, indicating poor capital efficiency.
- The company's liquidity position is weak, with a current ratio below 1 and negative free cash flow.
- Revenue is not diversified across segments or geographies, increasing operational risk.
- The company is not currently generating positive operating income and is reporting a net loss.
- The risk of future capital raising and potential share dilution exists due to the company's negative net cash position.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.